A HECT Ubiquitin-Protein Ligase as a Novel Candidate Gene for Altered Quinine and Quinidine Responses in

English version České info

Quinine, a natural product from cinchona bark, has been used in the treatment of malaria for centuries. Unfortunately, a progressive loss in responsiveness of the human malaria parasite Plasmodium falciparum to quinine has been observed, particularly in Southeast Asia, where cases of quinine treatment failure regularly occur. To better understand how P. falciparum defends itself against the cytotoxic activity of quinine, we have conducted comparative linkage analyses in the F1 progeny of a genetic cross where we assessed the susceptibility and the amount of intracellular accumulation of quinine and of its stereoisomer quinidine. These data identified a novel candidate gene encoding a HECT ubiquitin-protein ligase that might contribute to altered quinine responsiveness. The identification of this novel gene might improve the surveillance of quinine-resistant malaria parasites in the field and aid the preservation of this valuable antimalarial drug.

Vyšlo v časopise: A HECT Ubiquitin-Protein Ligase as a Novel Candidate Gene for Altered Quinine and Quinidine Responses in. PLoS Genet 10(5): e32767. doi:10.1371/journal.pgen.1004382
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1004382

Souhrn

Zdroje

1. World Health Organization (2012) World Malaria Report 2012. Geneva: World Health Organization.

2. World Health Organization (2010) Guidelines for the treatment of malaria — 2nd edition. Geneva: World Health Organization.

3. PukrittayakameeS, SupanaranondW, LooareesuwanS, VanijanontaS, WhiteNJ (1994) Quinine in severe falciparum malaria: evidence of declining efficacy in Thailand. Trans R Soc Trop Med Hyg 88: 324–327.

4. HuttingerF, SatimaiW, WernsdorferG, WiedermannU, CongpuongK, et al. (2010) Sensitivity to artemisinin, mefloquine and quinine of Plasmodium falciparum in northwestern Thailand. Wien Klin Wochenschr 122 Suppl 352–56.

5. ChaijaroenkulW, WisedpanichkijR, Na-BangchangK (2010) Monitoring of in vitro susceptibilities and molecular markers of resistance of Plasmodium falciparum isolates from Thai-Myanmar border to chloroquine, quinine, mefloquine and artesunate. Acta Trop 113: 190–194.

6. DemarM, CarmeB (2004) Plasmodium falciparum in vivo resistance to quinine: description of two RIII responses in French Guiana. Am J Trop Med Hyg 70: 125–127.

7. Cerutti JuniorC, MarquesC, AlencarFE, DurlacherRR, AlweenA, et al. (1999) Antimalarial drug susceptibility testing of Plasmodium falciparum in Brazil using a radioisotope method. Mem Inst Oswaldo Cruz 94: 803–809.

8. GonzalezIJ, VarelaRE, MurilloC, FerroBE, SalasJ, et al. (2003) Polymorphisms in cg2 and pfcrt genes and resistance to chloroquine and other antimalarials in vitro in Plasmodium falciparum isolates from Colombia. Trans R Soc Trop Med Hyg 97: 318–324.

9. NsobyaSL, KiggunduM, NanyunjaS, JolobaM, GreenhouseB, et al. (2010) In vitro sensitivities of Plasmodium falciparum to different antimalarial drugs in Uganda. Antimicrob Agents Chemother 54: 1200–1206.

10. EganTJ, NcokaziKK (2005) Quinoline antimalarials decrease the rate of beta-hematin formation. J Inorg Biochem 99: 1532–1539.

11. AlumasaJN, GorkaAP, CasabiancaLB, ComstockE, de DiosAC, et al. (2011) The hydroxyl functionality and a rigid proximal N are required for forming a novel non-covalent quinine-heme complex. J Inorg Biochem 105: 467–475.

12. SanchezCP, RotmannA, SteinWD, LanzerM (2008) Polymorphisms within PfMDR1 alter the substrate specificity for anti-malarial drugs in Plasmodium falciparum. Mol Microbiol 70: 786–798.

13. PleeterP, LekostajJK, RoepePD (2010) Purified Plasmodium falciparum multi-drug resistance protein (PfMDR 1) binds a high affinity chloroquine analogue. Mol Biochem Parasitol 173: 158–161.

14. CowmanAF, KarczS, GalatisD, CulvenorJG (1991) A P-glycoprotein homologue of Plasmodium falciparum is localized on the digestive vacuole. J Cell Biol 113: 1033–1042.

15. FerdigMT, CooperRA, MuJ, DengB, JoyDA, et al. (2004) Dissecting the loci of low-level quinine resistance in malaria parasites. Mol Microbiol 52: 985–997.

16. OkomboJ, OhumaE, PicotS, NzilaA (2011) Update on genetic markers of quinine resistance in Plasmodium falciparum. Mol Biochem Parasitol 177: 77–82.

17. CooperRA, FerdigMT, SuXZ, UrsosLM, MuJ, et al. (2002) Alternative mutations at position 76 of the vacuolar transmembrane protein PfCRT are associated with chloroquine resistance and unique stereospecific quinine and quinidine responses in Plasmodium falciparum. Mol Pharmacol 61: 35–42.

18. NkrumahLJ, RiegelhauptPM, MouraP, JohnsonDJ, PatelJ, et al. (2009) Probing the multifactorial basis of Plasmodium falciparum quinine resistance: evidence for a strain-specific contribution of the sodium-proton exchanger PfNHE. Mol Biochem Parasitol 165: 122–131.

19. BennettTN, PatelJ, FerdigMT, RoepePD (2007) Plasmodium falciparum Na+/H+ exchanger activity and quinine resistance. Mol Biochem Parasitol 153: 48–58.

20. SanchezCP, McLeanJE, SteinW, LanzerM (2004) Evidence for a substrate specific and inhibitable drug efflux system in chloroquine resistant Plasmodium falciparum strains. Biochemistry 43: 16365–16373.

21. SanchezCP, SteinWD, LanzerM (2008) Dissecting the components of quinine accumulation in Plasmodium falciparum. Mol Microbiol 67: 1081–1093.

22. MartinRE, MarchettiRV, CowanAI, HowittSM, BroerS, et al. (2009) Chloroquine transport via the malaria parasite's chloroquine resistance transporter. Science 325: 1680–1682.

23. MuJ, MyersRA, JiangH, LiuS, RicklefsS, et al. (2010) Plasmodium falciparum genome-wide scans for positive selection, recombination hot spots and resistance to antimalarial drugs. Nat Genet 42: 268–271.

24. ParkDJ, LukensAK, NeafseyDE, SchaffnerSF, ChangHH, et al. (2012) Sequence-based association and selection scans identify drug resistance loci in the Plasmodium falciparum malaria parasite. Proc Natl Acad Sci U S A 109: 13052–13057.

25. OkomboJ, KiaraSM, RonoJ, MwaiL, PoleL, et al. (2010) In vitro activities of quinine and other antimalarials and pfnhe polymorphisms in Plasmodium isolates from Kenya. Antimicrob Agents Chemother 54: 3302–3307.

26. HenryM, BriolantS, ZettorA, PelleauS, BaragattiM, et al. (2009) Plasmodium falciparum Na+/H+ exchanger 1 transporter is involved in reduced susceptibility to quinine. Antimicrob Agents Chemother 53: 1926–1930.

27. SidhuAB, Verdier-PinardD, FidockDA (2002) Chloroquine resistance in Plasmodium falciparum malaria parasites conferred by pfcrt mutations. Science 298: 210–213.

28. LakshmananV, BrayPG, Verdier-PinardD, JohnsonDJ, HorrocksP, et al. (2005) A critical role for PfCRT K76T in Plasmodium falciparum verapamil-reversible chloroquine resistance. Embo J 24: 2294–2305.

29. BaliraineFN, NsobyaSL, AchanJ, TibenderanaJK, TalisunaAO, et al. (2011) Limited ability of Plasmodium falciparum pfcrt, pfmdr1, and pfnhe1 polymorphisms to predict quinine in vitro sensitivity or clinical effectiveness in Uganda. Antimicrob Agents Chemother 55: 615–622.

30. ReedMB, SalibaKJ, CaruanaSR, KirkK, CowmanAF (2000) Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum. Nature 403: 906–909.

31. SidhuAB, ValderramosSG, FidockDA (2005) pfmdr1 Mutations contribute to quinine resistance and enhance mefloquine and artemisinin sensitivity in Plasmodium falciparum. Mol Microbiol 57: 913–926.

32. SanchezCP, DaveA, SteinWD, LanzerM (2010) Transporters as mediators of drug resistance in Plasmodium falciparum. Int J Parasitol 40: 1109–1118.

33. LehaneAM, KirkK (2010) Efflux of a range of antimalarial drugs and ‘chloroquine resistance reversers’ from the digestive vacuole in malaria parasites with mutant PfCRT. Mol Microbiol 77: 1039–1051.

34. RohrbachP, SanchezCP, HaytonK, FriedrichO, PatelJ, et al. (2006) Genetic linkage of pfmdr1 with food vacuolar solute import in Plasmodium falciparum. Embo J 25: 3000–3011.

35. PontsN, YangJ, ChungDW, PrudhommeJ, GirkeT, et al. (2008) Deciphering the ubiquitin-mediated pathway in apicomplexan parasites: a potential strategy to interfere with parasite virulence. PLoS One 3: e2386.

36. HwangCS, ShemorryA, AuerbachD, VarshavskyA (2010) The N-end rule pathway is mediated by a complex of the RING-type Ubr1 and HECT-type Ufd4 ubiquitin ligases. Nat Cell Biol 12: 1177–1185.

37. SuX, FerdigMT, HuangY, HuynhCQ, LiuA, et al. (1999) A genetic map and recombination parameters of the human malaria parasite Plasmodium falciparum. Science 286: 1351–1353.

38. SaJM, TwuO, HaytonK, ReyesS, FayMP, et al. (2009) Geographic patterns of Plasmodium falciparum drug resistance distinguished by differential responses to amodiaquine and chloroquine. Proc Natl Acad Sci U S A 106: 18883–18889.

39. MartinSK, OduolaAM, MilhousWK (1987) Reversal of chloroquine resistance in Plasmodium falciparum by verapamil. Science 235: 899–901.

40. PatelJJ, ThackerD, TanJC, PleeterP, CheckleyL, et al. (2010) Chloroquine susceptibility and reversibility in a Plasmodium falciparum genetic cross. Mol Microbiol 78: 770–787.

41. WallerKL, MuhleRA, UrsosLM, HorrocksP, Verdier-PinardD, et al. (2003) Chloroquine resistance modulated in vitro by expression levels of the Plasmodium falciparum chloroquine resistance transporter. J Biol Chem 278: 33593–33601.

42. SanchezCP, MayerS, NurhasanahA, SteinWD, LanzerM (2011) Genetic linkage analyses redefine the roles of PfCRT and PfMDR1 in drug accumulation and susceptibility in Plasmodium falciparum. Mol Microbiol 82: 865–878.

43. MuJ, FerdigMT, FengX, JoyDA, DuanJ, et al. (2003) Multiple transporters associated with malaria parasite responses to chloroquine and quinine. Mol Microbiol 49: 977–989.

44. JiangH, YiM, MuJ, ZhangL, IvensA, et al. (2008) Detection of genome-wide polymorphisms in the AT-rich Plasmodium falciparum genome using a high-density microarray. BMC Genomics 9: 398.

45. DhariaNV, SidhuAB, CasseraMB, WestenbergerSJ, BoppSE, et al. (2009) Use of high-density tiling microarrays to identify mutations globally and elucidate mechanisms of drug resistance in Plasmodium falciparum. Genome Biol 10: R21.

46. KidgellC, VolkmanSK, DailyJ, BorevitzJO, PlouffeD, et al. (2006) A systematic map of genetic variation in Plasmodium falciparum. PLoS Pathog 2: e57.

47. ScheffnerM, KumarS (2013) Mammalian HECT ubiquitin-protein ligases: Biological and pathophysiological aspects. Biochim Biophys Acta 1843: 61–74.

48. BeaudenonS, DasturA, HuibregtseJM (2005) Expression and assay of HECT domain ligases. Methods Enzymol 398: 112–125.

49. MasperoE, MariS, ValentiniE, MusacchioA, FishA, et al. (2011) Structure of the HECT:ubiquitin complex and its role in ubiquitin chain elongation. EMBO Rep 12: 342–349.

50. AgrawalS, ChungDW, PontsN, van DoorenGG, PrudhommeJ, et al. (2013) An apicoplast localized ubiquitylation system is required for the import of nuclear-encoded plastid proteins. PLoS Pathog 9: e1003426.

51. HuibregtseJM, ScheffnerM, BeaudenonS, HowleyPM (1995) A family of proteins structurally and functionally related to the E6-AP ubiquitin-protein ligase. Proc Natl Acad Sci U S A 92: 2563–2567.

52. World Health Organization (2010) Global report on antimalarial drug efficacy and drug resistance: 2000–2010. World Health Organization.

53. ParkerD, LerdpromR, SrisatjarakW, YanG, SattabongkotJ, et al. (2012) Longitudinal in vitro surveillance of Plasmodium falciparum sensitivity to common anti-malarials in Thailand between 1994 and 2010. Malar J 11: 290.

54. TynerSD, LonC, SeY, BethellD, SocheatD, et al. (2012) Ex vivo drug sensitivity profiles of Plasmodium falciparum field isolates from Cambodia and Thailand, 2005 to 2010, determined by a histidine-rich protein-2 assay. Malar J 11: 198.

55. LimP, WongsrichanalaiC, ChimP, KhimN, KimS, et al. (2010) Decreased in vitro susceptibility of Plasmodium falciparum isolates to artesunate, mefloquine, chloroquine, and quinine in Cambodia from 2001 to 2007. Antimicrob Agents Chemother 54: 2135–2142.

56. FidockDA, NomuraT, TalleyAK, CooperRA, DzekunovSM, et al. (2000) Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Mol Cell 6: 861–871.

57. PoyomtipT, SuwandittakulN, SitthichotN, KhositnithikulR, Tan-ariyaP, et al. (2012) Polymorphisms of the pfmdr1 but not the pfnhe-1 gene is associated with in vitro quinine sensitivity in Thai isolates of Plasmodium falciparum. Malar J 11: 7.

58. BriolantS, PelleauS, BogreauH, HovetteP, ZettorA, et al. (2011) In vitro susceptibility to quinine and microsatellite variations of the Plasmodium falciparum Na+/H+ exchanger (Pfnhe-1) gene: the absence of association in clinical isolates from the Republic of Congo. Malar J 10: 37.

59. BeezD, SanchezCP, SteinWD, LanzerM (2011) Genetic predisposition favors the acquisition of stable artemisinin resistance in malaria parasites. Antimicrob Agents Chemother 55: 50–55.

60. YuanJ, ChengKC, JohnsonRL, HuangR, PattaradilokratS, et al. (2011) Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets. Science 333: 724–729.

61. LaCountDJ, VignaliM, ChettierR, PhansalkarA, BellR, et al. (2005) A protein interaction network of the malaria parasite Plasmodium falciparum. Nature 438: 103–107.

62. ChungDW, PontsN, PrudhommeJ, RodriguesEM, Le RochKG (2012) Characterization of the ubiquitylating components of the human malaria parasite's protein degradation pathway. PLoS One 7: e43477.

63. JohnsonES, MaPC, OtaIM, VarshavskyA (1995) A proteolytic pathway that recognizes ubiquitin as a degradation signal. J Biol Chem 270: 17442–17456.

64. LiGD (2007) Plasmodium falciparum chloroquine resistance marker protein (Pfcrmp) may be a chloroquine target protein in nucleus. Med Hypotheses 68: 332–334.

65. ZhangY, QuX, HuX, YangX, HouK, et al. (2009) Reversal of P-glycoprotein-mediated multi-drug resistance by the E3 ubiquitin ligase Cbl-b in human gastric adenocarcinoma cells. J Pathol 218: 248–255.

66. LiuM, AnejaR, WangH, SunL, DongX, et al. (2008) Modulation of multidrug resistance in cancer cells by the E3 ubiquitin ligase seven-in-absentia homologue 1. J Pathol 214: 508–514.

67. ZhangZ, WuJY, HaitWN, YangJM (2004) Regulation of the stability of P-glycoprotein by ubiquitination. Mol Pharmacol 66: 395–403.

68. HuntP, AfonsoA, CreaseyA, CulletonR, SidhuAB, et al. (2007) Gene encoding a deubiquitinating enzyme is mutated in artesunate- and chloroquine-resistant rodent malaria parasites. Mol Microbiol 65: 27–40.

69. KuhnY, SanchezCP, AyoubD, SaridakiT, van DorsselaerA, et al. (2010) Trafficking of the phosphoprotein PfCRT to the digestive vacuolar membrane in Plasmodium falciparum. Traffic 11: 236–249.

70. TragerW, JensenJB (1976) Human malaria parasites in continuous culture. Science 193: 673–675.

71. LambrosC, VanderbergJP (1979) Synchronization of Plasmodium falciparum erythrocytic stages in culture. J Parasitol 65: 418–420.

72. CrabbBS, RugM, GilbergerTW, ThompsonJK, TrigliaT, et al. (2004) Transfection of the human malaria parasite Plasmodium falciparum. Methods Mol Biol 270: 263–276.

73. SaridakiT, SanchezCP, PfahlerJ, LanzerM (2008) A conditional export system provides new insights into protein export in Plasmodium falciparum-infected erythrocytes. Cell Microbiol 10: 2483–2495.

74. FidockDA, WellemsTE (1997) Transformation with human dihydrofolate reductase renders malaria parasites insensitive to WR99210 but does not affect the intrinsic activity of proguanil. Proc Natl Acad Sci U S A 94: 10931–10936.

75. SanchezCP, SteinW, LanzerM (2003) Trans stimulation provides evidence for a drug efflux carrier as the mechanism of chloroquine resistance in Plasmodium falciparum. Biochemistry 42: 9383–9394.

76. HaleyCS, KnottSA (1992) A simple regression method for mapping quantitative trait loci in line crosses using flanking markers. Heredity 69: 315–324.

77. TonkinCJ, van DoorenGG, SpurckTP, StruckNS, GoodRT, et al. (2004) Localization of organellar proteins in Plasmodium falciparum using a novel set of transfection vectors and a new immunofluorescence fixation method. Mol Biochem Parasitol 137: 13–21.

78. CyrklaffM, SanchezCP, KilianN, BisseyeC, SimporeJ, et al. (2011) Hemoglobins S and C interfere with actin remodeling in Plasmodium falciparum-infected erythrocytes. Science 334: 1283–1286.

79. NesslerS, FriedrichO, BakouhN, FinkRH, SanchezCP, et al. (2004) Evidence for activation of endogenous transporters in Xenopus laevis oocytes expressing the Plasmodium falciparum chloroquine resistance transporter, PfCRT. J Biol Chem 279: 39438–39446.

80. BullenHE, CharnaudSC, KalanonM, RiglarDT, DekiwadiaC, et al. (2012) Biosynthesis, localization, and macromolecular arrangement of the Plasmodium falciparum translocon of exported proteins (PTEX). J Biol Chem 287: 7871–7884.

81. IngmundsonA, NaharC, BrinkmannV, LehmannMJ, MatuschewskiK (2012) The exported Plasmodium berghei protein IBIS1 delineates membranous structures in infected red blood cells. Mol Microbiol 83: 1229–1243.

82. LeeC, KimJ, ShinSG, HwangS (2006) Absolute and relative QPCR quantification of plasmid copy number in Escherichia coli. J Biotechnol 123: 273–280.

83. PriceRN, UhlemannAC, BrockmanA, McGreadyR, AshleyE, et al. (2004) Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. Lancet 364: 438–447.